These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 34171762)

  • 1. Evaluating the modified common liability hypothesis of psychiatric comorbidity.
    Blanco C; Wall MM; Feng T; Olfson M
    J Psychiatr Res; 2021 Sep; 141():9-15. PubMed ID: 34171762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirically derived subgroups of bipolar I patients with different comorbidity patterns of anxiety and substance use disorders in Han Chinese population.
    Tsai HC; Lu MK; Yang YK; Huang MC; Yeh TL; Chen WJ; Lu RB; Kuo PH
    J Affect Disord; 2012 Jan; 136(1-2):81-89. PubMed ID: 21906818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use disorders increase the odds of subsequent mood disorders.
    Kenneson A; Funderburk JS; Maisto SA
    Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature.
    Turner S; Mota N; Bolton J; Sareen J
    Depress Anxiety; 2018 Sep; 35(9):851-860. PubMed ID: 29999576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice versa.
    Wolitzky-Taylor K; Bobova L; Zinbarg RE; Mineka S; Craske MG
    Addict Behav; 2012 Aug; 37(8):982-5. PubMed ID: 22503436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
    McEvoy PM; Grove R; Slade T
    Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and age of onset of psychiatric disorders in Australian men.
    Williams LJ; Jacka FN; Pasco JA; Coulson CE; Quirk SE; Stuart AL; Berk M
    Aust N Z J Psychiatry; 2016 Jul; 50(7):678-84. PubMed ID: 26546500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.
    Vilar-Ribó L; Cabana-Domínguez J; Alemany S; Llonga N; Arribas L; Grau-López L; Daigre C; Cormand B; Fernàndez-Castillo N; Ramos-Quiroga JA; Soler Artigas M; Ribasés M
    Transl Psychiatry; 2024 May; 14(1):221. PubMed ID: 38811559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of early onset mental disorders among long-term disability claimants.
    Cornelius LR; van der Klink JJ; de Boer MR; Brouwer S; Groothoff JW
    Disabil Rehabil; 2016; 38(6):520-7. PubMed ID: 25974228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology.
    Merikangas KR; Mehta RL; Molnar BE; Walters EE; Swendsen JD; Aguilar-Gaziola S; Bijl R; Borges G; Caraveo-Anduaga JJ; DeWit DJ; Kolody B; Vega WA; Wittchen HU; Kessler RC
    Addict Behav; 1998; 23(6):893-907. PubMed ID: 9801724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis.
    Lai HM; Cleary M; Sitharthan T; Hunt GE
    Drug Alcohol Depend; 2015 Sep; 154():1-13. PubMed ID: 26072219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions.
    Wu LT; Howard MO
    Drug Alcohol Depend; 2007 May; 88(2-3):146-55. PubMed ID: 17129683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secular trends in first hospitalizations for major mood disorders with comorbid substance use.
    Minnai GP; Tondo L; Salis P; Ghiani C; Manfredi A; Paluello MM; Baethge C; Baldessarini RJ
    Int J Neuropsychopharmacol; 2006 Jun; 9(3):319-26. PubMed ID: 16316480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample.
    Blanco C; Okuda M; Wang S; Liu SM; Olfson M
    JAMA Psychiatry; 2014 Nov; 71(11):1246-53. PubMed ID: 25208305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsyndromal depression among older adults in the USA: prevalence, comorbidity, and risk for new-onset psychiatric disorders in late life.
    Laborde-Lahoz P; El-Gabalawy R; Kinley J; Kirwin PD; Sareen J; Pietrzak RH
    Int J Geriatr Psychiatry; 2015 Jul; 30(7):677-85. PubMed ID: 25345806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
    Fatseas M; Serre F; Swendsen J; Auriacombe M
    Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.